The Australian Technical Advisory Group on Immunisation (ATAGI) recommends an additional dose of COVID-19 vaccine for winter for selected population groups (see attached summary and poster) who are at greatest risk of severe illness from COVID-19 and who have received their primary vaccination and first booster dose.
The Minister for Health and Ambulance Services invites interested persons from a wide range of professional backgrounds to apply for membership of the inaugural Voluntary Assisted Dying Review Board.
The Department of Health has invited the College to nominate a representative to participate in the National Initial Assessment and Referral (IAR) Project Expert Advisory Group (EAG).
The College is calling for expressions of interest from QLD Fellows to represent ACRRM on the QLD Rural and Remote Hospital Services Medical and Dental Credentialing and Scope of Clinical Practice Committee.
The Australian College of Rural and Remote Medicine (ACRRM) is pleased to announce Dr Daniel Wilson has been appointed as a director on the ACRRM Board. Dr Wilson is an ACRRM Registrar with advanced skills in obstetrics, completing his Rural Generalist training in Maryborough, Victoria.
To protect the health and safety of staff and visitors throughout the COVID-19 pandemic, ACRRM requires all people attending the national office to present evidence of COVID-19 vaccination status.
Image-based prescribing, implemented at the beginning of the COVID-19 pandemic, will end on 31 March 2022. Find out what the alternatives are to Image-based prescribing, post 31 March.
The COVID-19 pandemic continues to create challenges for the Australian health system. In some instances, this may impact the ability of general practices to participate in on-site accreditation assessments to the Royal Australian College of General Practitioners' Standards for general practice 5th edition.
After 31 March 2022, image-based prescribing will not be available for use outside of a hospital setting. While image-based prescribing arrangements will cease in the community setting, healthcare providers will continue to have options that existed before image-based prescribing (in addition to electronic prescribing) to enable remote support to their patients.
Services Australia is expediting processes due to the recent extreme weather events occurring in New South Wales and Queensland, to ensure continued care is provided for patients in disaster affected areas.
ACRRM, in collaboration with the Victorian Rural Generalist Program (VRGP) and the Joint Consultative Committee on Anaesthesia (JCCA), oversaw the successful running of the Victorian JCCA’s first ever online exam recently. The exam was conducted virtually from the College’s national office in Brisbane, allowing ACRRM to facilitate the exam delivery and the invigilation, on behalf of the VRGP.
A research article has recently been published in the Journal of Rural Health, involving collaboration between three past Presidents of ACRRM, and international researchers.
The College continues to consult with the Australian Medical Council, the Medical Board of Australia and the Australian Health Practitioners Regulation Agency on the requirements of the Professional Performance Framework and the accreditation criteria for CPD homes before they are officially introduced in 2023.
The Australian Technical Advisory Group on Immunisation (ATAGI) has released version 3 of its recommendations on the use of additional (booster) doses of COVID-19 vaccine.
A review of the National Medicines Policy (NMP) was commissioned in recognition of the substantial changes to the health landscape since the policy was published in 2000. ACRRM has taken the opportunity to comment on the draft of the revised NMP.
Under the Australian Government Living with COVID Primary Care package, personal protective equipment (PPE) bundles and pulse oximeters are being made available to eligible general practitioners (GPs), Aboriginal and Community Controlled Health Services (ACCHSs)...
As of Tuesday 1 March, Lagevrio (molnupiravir) has been listed on the Pharmaceutical Benefits Scheme (PBS) Section 85 program as an Authority Required (Streamlined) benefit for patients with mild-moderate COVID-19 who have a high risk for developing severe disease, reducing the need for admission to hospital.
The Australian Government has published The National Guidance for doctors assessing workers exposed to respirable crystalline silica dust, with specific reference to the occupational respiratory diseases associated with engineered stone.